lilly novo nordisk - Search News

News

Obesity drug maker Novo Nordisk ousts CEO

Euronews on MSN · 15m

Novo Nordisk CEO steps down amid growing competition for weight loss drugs

Lars Fruergaard Jørgensen, who has led the pharmaceutical giant since 2017, joined the firm in 1991. View on euronews

Reuters on MSN · 9m

Obesity drug maker Novo Nordisk ousts CEO as competition weighs

Wegovy-maker Novo Nordisk said on Friday its CEO Lars Fruergaard Jorgensen will step down over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market. Under Jorgensen's leadership,

Moneyweb · 24m

Novo ousts CEO Jorgensen after Lilly competition hits shares

The Danish company said Jorgensen is leaving by mutual agreement with the board, though he’ll continue as chief 'for a period to support a smooth transition to new leadership.'

Indianapolis Business Journal1d

Novo Nordisk inks $2.2B deal to develop weight-loss pill to rival Lilly’s orforglipron

Indianapolis-based Eli Lilly & Co. announced promising results from a large study of its own tablet in diabetes patients last ...

FDA Accepts Novo Nordisk’s Application for Oral Wegovy: 5 Things to Know

Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...

Novo Doubles Down on Oral Obesity Meds With Septerna Deal Worth up to $2.4B

Currently trailing Eli Lilly and Structure Therapeutics in the oral weight loss space, Novo Nordisk strikes a deal with ...

Fierce Biotech2d

Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs

Novo Nordisk is making yet another bet on obesity, offering Septerna more than $200 million in upfront and near-term payments ...

Novo Nordisk strikes deal with Septerna to develop obesity pills

Novo Nordisk is partnering with the biotech Septerna to develop oral obesity drugs, as it aims for more convenient weight ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results